Definitive Contract 36C24521C0180
Award Date
9/30/21
Potential Completion Date
3/12/25
Potential Value
$972K
Funding Federal Agency
Department of Veterans Affairs
Contracting Federal Agency
Veterans Integrated Service Network 5
Ultimate Awardee
University Of Texas System
PSC Category
Q527 - Medical- Nuclear Medicine
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Richmond, VA 23249, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the U.S. Department of Veterans Affairs (VA) to The University of Texas M.D. Anderson Cancer Center (MD Anderson) for the peer review of radiation quality assurance operations. The contract has a firm fixed price of $989,135.00 and a completion date of September 29, 2018. MD Anderson is a comprehensive cancer treatment and research center that has received numerous prime and subcontract awards from federal agencies, including the National Institutes of...
The Department of Veterans Affairs (VA) has awarded a $1,165,320.00 firm-fixed-price purchase order to the University of Texas MD Anderson Cancer Center to provide medical physics peer review services for the VA's National Radiation Oncology Program Office. This 3-year contract, which does not have a set-aside designation, will require MD Anderson to perform periodic on-site dosimetry and quality assurance reviews, annual remote audits of treatment machine calibration, and credentialing of...
This is a prime contract awarded by the U.S. government to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is for $6,155,674.00 and is a Definitive Contract with Cost No Fee pricing. The place of performance is Texas, USA. The contract is for biomedical (applied/exploratory) services and does not have a set-aside designation. MD Anderson Cancer Center, a comprehensive cancer treatment and research center, has received this prime...
This is a definitive contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System doing business as MD Anderson Cancer Center. The $440,456.00 Firm Fixed Price contract is for genome sequencing services, with a completion date of September 17, 2020. The contract has no set-aside designation. MD Anderson Cancer Center is a comprehensive...
This is a firm-fixed-price definitive contract awarded by the Department of Veterans Affairs to the University of Texas Health Science Center at Houston (UTHealth) to provide medical physics peer review of radiation therapy quality assurance. The potential value of the contract is $793,035.00 and the period of performance runs through September 29, 2021. UTHealth is a state-controlled institution of higher learning that provides healthcare services, medical education, and biomedical research....
This is a three-year, $13,481,325.00 definitive contract awarded by the National Cancer Institute (NCI) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract supports a Phase II chemoprevention clinical trial in patients with adenomatous polyposis coli, a genetic condition that increases cancer risk. The contract does not have a small business set-aside designation. MD Anderson Cancer Center, a comprehensive cancer research and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract for $150,904.40 to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for an "Invasive Mold Data Acquisition" project. The contract does not have a set-aside designation and was awarded on July 15, 2019, with a completion date of July 14, 2020. MD Anderson Cancer Center is a comprehensive cancer treatment...
This federal contract award, valued at $478,008.47, was granted by the National Aeronautics and Space Administration (NASA) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract aims to acquire data on neurocognitive/behavioral impairments and associated biomarkers observed in patients undergoing cranial exposure to ionizing radiation, with a focus on non-invasive imaging modalities and serum biomarkers. This work will provide benchmark...
This is a delivery order issued under the National Cancer Institute's Cancer Prevention Agent Development Program 2012-2017 indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to provide core infrastructure support for the program. The award has a ceiling value of $725,737.89 and an ultimate completion date of September 23, 2015. The contract is a cost-no-fee type...
This federal contract was awarded by the Department of Health and Human Services' Food and Drug Administration to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract, valued at $283,546.12, is for a study titled "Modular Application of Surface Technology for the Generation of Antigen-Specific T Cells." It is a definitive contract with a cost-no-fee pricing type, awarded on September 13, 2019 with a completion date of...